Dr. Abdullah Alshammaa, MD

Dr. Alshammaa practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Alshammaa's NPI, 1073908869, was assigned on March 30, 2015. Dr. Alshammaa holds Michigan license 4301507824.

Dr. Alshammaa's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Alshammaa's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Alshammaa is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Alshammaa to 4 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alshammaa practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Alshammaa's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Alshammaa's licenses on file in 2 states: Michigan and California.

CMS data shows 321 Medicare services from Dr. Alshammaa across 11 procedure codes in 2024, for 258 Medicare patients. Medicare paid $26,042 for them.

CMS counts 258 Medicare patients who saw Dr. Alshammaa in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alshammaa's median patient age at 58, with 51% women.

In 2024, Dr. Alshammaa wrote 469 Medicare Part D claims for 106 patients. 82% of them were for generic drugs. CMS names the drug for 341 of them, across 16 drugs with 11 or more claims each, at $54,489 in total drug cost. In 2023, CMS named 321 claims across 12 drugs.

Dr. Alshammaa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alshammaa as offering telehealth.

CMS Open Payments shows 35 general payments to Dr. Alshammaa from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $500.